{
    "organizations": [],
    "uuid": "d633493c918f1dc221bca6fd3a557be741d8c0b2",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/polyphor-ipo/swiss-speciality-drugs-company-polyphor-announces-plans-to-float-idUSZ8N1QN01M",
    "ord_in_thread": 0,
    "title": "Swiss speciality drugs company Polyphor announces plans to float",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "ZURICH, April 9 (Reuters) - Swiss speciality pharmaceuticals company Polyphor on Monday said it plans to raise 100 million to 150 million Swiss francs ($104.21 million to $156.32 million) by floating on the Swiss stock exchange.\nThe company said it would use the funds to develop Murepavadin, a drug to treat a strain of pneumonia with high levels of mortality. ($1 = 0.9596 Swiss francs) (Reporting by John Revill, editing by John Miller)\n ",
    "published": "2018-04-09T13:19:00.000+03:00",
    "crawled": "2018-04-10T12:37:18.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "zurich",
        "april",
        "reuters",
        "swiss",
        "speciality",
        "pharmaceutical",
        "company",
        "polyphor",
        "monday",
        "said",
        "plan",
        "raise",
        "million",
        "million",
        "swiss",
        "franc",
        "million",
        "million",
        "floating",
        "swiss",
        "stock",
        "exchange",
        "company",
        "said",
        "would",
        "use",
        "fund",
        "develop",
        "murepavadin",
        "drug",
        "treat",
        "strain",
        "pneumonia",
        "high",
        "level",
        "mortality",
        "swiss",
        "franc",
        "reporting",
        "john",
        "revill",
        "editing",
        "john",
        "miller"
    ]
}